Teva Pharmaceutical Industries Limited (VIE:TEVA)

Market Cap	35.64B +129.0%
Revenue (ttm)	15.16B +4.1%
Net Income	617.96M
EPS	0.53
Shares Out	n/a
PE Ratio	57.68
Forward PE	12.26
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8
Open	30.10
Previous Close	30.10
Day's Range	29.80 - 30.10
52-Week Range	13.55 - 31.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About VIE:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Pharmaceutical Preparations
• Founded: 1901
• Employees: 32,008
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

Financial numbers in USD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 7, 2026

Data Sources Report a data error